van Oeveren W - Search Results

1

Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate.

Gu YJ, Obster R, Haan J, Gallandat Huet RC, Eijgelaar A, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Artif Organs. 1993 Jul;17(7):660-5. doi: 10.1111/j.1525-1594.1993.tb00611.x. Artif Organs. 1993. PMID: 8338443 Clinical Trial.

2

Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.

Gu YJ, van Oeveren W, Boonstra PW, de Haan J, Wildevuur CR. Gu YJ, et al. Among authors: van oeveren w. Ann Thorac Surg. 1992 May;53(5):839-43. doi: 10.1016/0003-4975(92)91447-h. Ann Thorac Surg. 1992. PMID: 1315132

3

Blood compatibility of two different types of membrane oxygenator during cardiopulmonary bypass in infants.

Gu YJ, Boonstra PW, Akkerman C, Mungroop H, Tigchelaar I, Van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Int J Artif Organs. 1994 Oct;17(10):543-8. Int J Artif Organs. 1994. PMID: 7896428 Clinical Trial.

4

Activation of plasma components by leukocyte removal filters.

Gu YJ, Van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. ASAIO J. 1994 Jul-Sep;40(3):M598-601. doi: 10.1097/00002480-199407000-00069. ASAIO J. 1994. PMID: 8555585

5

Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate.

Gu YJ, deVries AJ, Boonstra PW, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Perfusion. 1995 Nov;10(6):425-30. doi: 10.1177/026765919501000606. Perfusion. 1995. PMID: 8747899 Clinical Trial.

6

Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery.

Gu YJ, de Vries AJ, Boonstra PW, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. J Thorac Cardiovasc Surg. 1996 Aug;112(2):494-500. doi: 10.1016/s0022-5223(96)70277-5. J Thorac Cardiovasc Surg. 1996. PMID: 8751518 Free article. Clinical Trial.

7

Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.

Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Ann Thorac Surg. 1998 May;65(5):1342-7. doi: 10.1016/s0003-4975(98)00223-9. Ann Thorac Surg. 1998. PMID: 9594864 Clinical Trial.

8

Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates.

Gu YJ, Obster R, de Haan J, Huet RC, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Transfus Sci. 1992;13(4):467-72. doi: 10.1016/0955-3886(92)90035-F. Transfus Sci. 1992. PMID: 10147741 No abstract available.

9

Leukocyte depletion during cardiac operation: a new approach through the venous bypass circuit.

Gu YJ, de Vries AJ, Vos P, Boonstra PW, van Oeveren W. Gu YJ, et al. Among authors: van oeveren w. Ann Thorac Surg. 1999 Mar;67(3):604-9. doi: 10.1016/s0003-4975(98)01262-4. Ann Thorac Surg. 1999. PMID: 10215195 Clinical Trial.

10

Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery.

Smit JJ, de Vries AJ, Gu YJ, van Oeveren W. Smit JJ, et al. Among authors: van oeveren w. Transfus Sci. 1999 Jun;20(3):151-65. doi: 10.1016/s0955-3886(99)00038-7. Transfus Sci. 1999. PMID: 10623356 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters